Table 6.
Model 1 | Model 2 | |||||||
---|---|---|---|---|---|---|---|---|
OR | CI | P-Value | n | OR | CI | P-Value | n | |
Depression (PHQ-9 ≥ 10) | 1.08 | 0.69–1.62 | 0.72 | 14,359 | 1.10 | 0.50–2.38 | 0.80 | 14,061 |
Anxiety (GAD-2 ≥ 3) | 1.15 | 0.70–1.78 | 0.55 | 14,288 | 1.48 | 0.63–3.30 | 0.35 | 13,991 |
PHQ-9 Patient Health Questionnaire, GAD-2 Generalized Anxiety Disorder Scale, OR Odds ratio, CI 95% confidence Interval
Model 1: logistic regression analysis adjusted for age, sex, socio-economic status; Model 2 additionally adjusted for systemic comorbidities (arterial hypertension, myocardial infarction, stroke, diabetes mellitus, chronic obstructive pulmonary disease, cancer), ocular diseases (cataract, macular degeneration, corneal diseases, diabetic retinopathy), visual acuity of the worse eye, IOP, antiglaucoma eye medications (Sympathomimetics, Parasympathomimetics, Carbonic anhydrase inhibitors, Beta-blockers, Prostaglandins) and general health status